-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Tuberculous meningitis is a disease
with a very high mortality and disability rate.
Early and targeted treatment can significantly improve prognosis
.
However, the principles of treatment for tuberculous meningitis are mostly derived from observational studies and clinical practice rather than well-designed controlled trials, so there is a lack of sufficient evidence
.
Early diagnosis is difficult, the presence of the blood-brain barrier and the prevalence of drug-resistant strains of tuberculosis make treatment more difficult
.
Here, we interpret the treatment options for tuberculous meningitis in the Fever Handbook, combined with multiple evidence-based evidence, and summarize the current treatment options for tuberculous meningitis
.
First, the choice of antituberculosis regimen for tuberculous meningitis
Antituberculosis drugs are selected in combination with blood-brain barrier permeability
Early use of fluoroquinolones (levofloxacin, gatifloxacin, ciprofloxacin) may be effective
.
2.
Treatment course of tuberculous meningitis
Third, the application of glucocorticoids in tuberculous meningitis
Fourth, the treatment plan for drug-resistant tuberculous meningitis
5.
Our research shows that linezolid can effectively treat severe tuberculous meningitis